Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients (COLLECT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
InDex Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01493960
First received: December 12, 2011
Last updated: June 16, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)